In conclusion, there is strong evidence that the apelin-apelin receptor signaling axis is perturbed in both PAH and HF and that modulation of this system by reintroduction of the downregulated apelin ligand or of ELA could be beneficial. This evidence concerns the gene APLNR and pulmonary arterial hypertension.